In-depth company and drug candidate breakdowns, from mechanism of action to regulatory pathway, financial runway, and competitive landscape—all in clear, structured due diligence reports.

Get comprehensive biotech intelligence in minutes that would take analysts days to compile manually, accelerating your investment research process.

Analyze mechanism of action, trial design, competitive positioning, addressable market, probability of success by phase, and commercial potential—all in one comprehensive candidate report.

Surface upcoming trial readouts, FDA decision dates, regulatory milestones, and partnership announcements that could move stock prices and impact investment theses.

Identify financial strain, patent cliffs, trial design risks, competitive threats, and regulatory hurdles before they impact valuation or derail your investment thesis.

Our system processes SEC filings, ClinicalTrials.gov data, and scientific publications to surface only what matters for investment decisions, cutting through dense regulatory and scientific jargon.